Skip to Main Content

Hired someone new and exciting? Promoting a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Amgen (AMGN) named Murdo Gordon as executive vice president of global commercial operations, replacing Anthony Hooper, who will be retiring. Previously, Gordon worked at Bristol-Myers Squibb (BMY), where he was chief commercial officer.


Amgen named Dr. David Reese as executive vice president of R&D, succeeding Sean Harper, who is retiring;

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!